Dual Effects of β(3) Integrin Subunit Expression on Human Pancreatic Cancer Models

por Marchán, S., Pérez-Torras, S., Vidal, A., Adan, J., Mitjans, F., Carbó, N., Mazo, A.
Publicado 2010

S100P antibody-mediated therapy as a new promising strategy for the treatment of pancreatic cancer

por Dakhel, S, Padilla, L, Adan, J, Masa, M, Martinez, J M, Roque, L, Coll, T, Hervas, R, Calvis, C, Messeguer, R, Mitjans, F, Hernández, J L
Publicado 2014